Immune checkpoint inhibitors have transformed cancer treatment but are not complexity-free. Nephrotoxicity is relatively exceptional but often underestimated. The occurrence of acute sort injury related to checkpoint prevention therapy is increasing accompanying the widespread use of these novel antagonistic-cancer agents. Diagnosis maybe challenging and postponed, which increases the risk of complications. Management consistently consists of treatment stop and corticosteroid therapy as determined. Vigilance and early diagnosis are the keys to better continuation and outcome.
Author(s) Details:
Amulya Prakash,
Haywood
Regional Medical Center, Edward Via College of Osteopathic Medicine, USA.
Please see the link here: https://stm.bookpi.org/NRAMMS-V6/article/view/12149
No comments:
Post a Comment